Three weeks after receiving the fourth dose of DAC, the patient developed fatigue and jaundice with significantly increased AST (3,041 U/L; reference <35 U/L), ALT (4,760 U/L; reference <35 U/L), lactate dehydrogenase (628 U/L; reference <215 U/L), and total bilirubin (21.5 mg/dL; reference <1.1 mg/dL) values. Two days later, she was hospitalized in a somnolent state with jaundice, arterial hypotension, and lactate acidosis. Diagnosis of acute irreversible liver failure prompted a high urgency liver transplantation that was performed the following day, after receiving approval by the ELAC (Eurotransplant Liver Advisory Committee) audit. One day after transplantation, the patient developed circulatory instability and catecholamine dependency with continuous peaks of transaminases (AST: 8,568 U/L; ALT: 4,207 U/L). Despite intensified treatment, the patient died 4 days later because of systemic inflammatory response syndrome, septic shock, and multiple organ failure.
We suspected DAC-induced hepatic (DIH) injury possibly owing to natural killer (NK)-cell hyperactivation, because drug reaction with eosinophilia and systemic symptoms (DRESS) and other causes of hepatic injury, including alcohol and drug abuse or viral hepatitis, could be excluded. A contribution of tizanidine, which was administered as co-medication after the fourth cycle of DAC treatment and has also been shown to induce serious liver injury as *Authors contributed equally to this work. a monotherapy, 5, 6 could not be excluded. Interestingly, tizanidine was the common denominator between this case and another fatal case of DIH injury in the SELECT trial. 5, 7 Immunohistochemistry of the explanted liver tissue of the patient with DIH revealed CD3 + T-cell infiltrates surrounded by damaged zones of CD16 + macrophages. The same observations were made for the liver tissue of a 39-year-old woman diagnosed with autoimmune hepatitis (AIH) 7 months after first diagnosis of MS ( figure 1A) as an example of an autoinflammatory disease of both CNS and liver. While CD4 + T-helper cells dominated in the patient with DIH, equal numbers of T-helper and cytotoxic CD8 + T cells were observed in the AIH liver tissue. Despite the fact that autoimmune liver disease has a wide pathophysiologic spectrum, more B-cell infiltrates were detected within the T-cell zones of the patient with DIH compared to AIH. Enrichment of granzyme B-expressing NKG2A
+ NK-cells in the DIH liver tissue suggests an active role of NK cells in hepatic injury.
In accordance with enriched B-cell infiltrates in the DIH liver, immune cell profiling of the blood revealed significantly enhanced circulating B cells (figure 1B), consisting mainly of naive B cells and increased proportions of autoreactive antibody expressing complement receptor (CD21) negative B cells. 8 Despite a DAC-induced increase of CD56 bright NK cells, the DIH case exhibited significantly decreased proportions of CD56 dim NK cells. 9, 10 Diminished cell-surface expression of the activating receptor DNAM-1 (DNAX Accessory Molecule-1), which has been recently identified as a crucial player in NK-and regulatory T(T reg )-cell mediated control of T-cell activity, on NK 6 and T reg 7 ( figure 1C ), suggests impaired immune regulatory function. Accordingly, proinflammatory granulocyte-macrophage colony-stimulating factor (GM-CSF) production was increased in circulating T cells of the patient with DIH ( figure 1D ). Increased expression of the liver homing receptor C-C chemokine receptor type 5 (CCR5) on CD56 bright NK cells and enhanced cytotoxic function as well as GM-CSF production in response to liver cells (figure 1E) indicated expanded liver invasion and hepatotoxicity of this subset. Finally, enhanced GM-CSF levels resulting from T-and NK-cell hyperactivation may drive the differentiation of CCR5-expressing proinflammatory M1-like monocytes leading to the highly increased frequencies observed in the blood of the patient with DIH ( figure 1F) . 11 Overall, our findings indicate DIH injury resulting from innate immune cell activation and impaired immune regulation. Although involvement of the liver frequently occurs in DRESS, this case does not fulfill critical criteria for DRESS such as hypereosinophilia, rashes, and reactivation of herpes viruses, 12, 13 thus, differing from the recently described DAC-induced DRESS cases.
